NextGen Biomed Ltd. Logo

NextGen Biomed Ltd.

R&D of biotech medical devices for diabetes care and topical skin treatments.

NXGN | TA

Overview

Corporate Details

ISIN(s):
IL0010839301
LEI:
Country:
Israel
Address:
132 Azrieli Towers Round Building Menachem Begin Street P.O. Box 14, 6701101 Tel Aviv
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

NextGen Biomed Ltd. is a research and development company operating in the biotechnology and medical device sectors. The company focuses on developing products such as the EyePen, an injection module designed for individuals with diabetes to monitor insulin dosage and timing. Its portfolio also includes pain-free auto-injectors, lancet devices, and the development of topical treatments for conditions like psoriasis. The company was formerly known as Sela Group.Com Ltd.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-06-30 18:01
Regulatory News Service
Trading in the company's shares (ISIN IL0010839301) will be renewed on Tuesday,…
Hebrew (modern) 158.5 KB
2024-05-01 10:36
Regulatory News Service
Trading in the company's shares has been suspended since the company has not ye…
Hebrew (modern) 78.8 KB
2024-04-18 19:36
Regulatory News Service
Suspension of trade due to failure in publishing financial reports-Notification
Hebrew (modern) 129.9 KB
2021-01-12 18:34
Regulatory News Service
On January 14, 2021, the company's securities will be transferred from the main…
Hebrew (modern) 251.9 KB

Automate Your Workflow. Get a real-time feed of all NextGen Biomed Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for NextGen Biomed Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
OPTIBIOTIX HEALTH PLC Logo
Develops microbiome-modulating ingredients and supplements to manage chronic lifestyle diseases.
United Kingdom OPTI
OXFORD BIODYNAMICS PLC Logo
Develops precision blood tests using 3D genomics for cancer diagnosis and therapy guidance.
United Kingdom OBD
Pharnext Logo France ALPHA
PHYSIOMICS PLC Logo
De-risks oncology drug development for pharma/biotech using modeling and simulation.
United Kingdom PYC
PILA PHARMA AB Logo
Clinical-stage biopharma developing a first-in-class oral drug for diabetes and obesity.
Sweden PILA
POOLBEG PHARMA PLC Logo
AI-led biopharma developing drugs for high-need diseases like CRS and metabolic disorders.
United Kingdom POLB
PROTEOME SCIENCES PLC Logo
CRO providing proteomics services & TMT® tags to biopharma for drug discovery & biomarkers.
United Kingdom PRM
PROVEXIS PLC Logo
Develops & licenses Fruitflow®, a patented ingredient for heart health in food & supplements.
United Kingdom PXS
Develops uncopiable atomic fingerprints for anti-counterfeiting, verifiable by smartphone.
United Kingdom N/A
QUANTUM BLOCKCHAIN TECHNOLOGIES PLC Logo
R&D firm using AI and quantum computing to create efficient technologies for Bitcoin mining.
United Kingdom QBT

Talk to a Data Expert

Have a question? We'll get back to you promptly.